Amadeus V Technology Fund closes on £110m

The fund – which targets early-stage, "deep-tech" investments across the UK – was launched in January 2018 with a target of £75m. It is larger than its predecessor, Amadeus IV Fund, which closed in 2014.

Amadeus is dedicated to investments across the technology sector. Since its inception in 1997, the firm has raised around $1bn and backed 170 companies.

Noticeable investments inked by the firm include cybersecurity vendor ForeScout; IVF genetic testing company Igenomix; B2B online marketplace IndiaMart; and speech recognition company VocalIQ, which was acquired by Apple.

Investors
Amadeus V Technology Fund received capital from a large base of LPs, including a cornerstone commitment provided by British Patient Capital.

Investments
The fund invests in seed and series-A startups specialised in science and engineering innovation. It has a special focus on artificial intelligence; machine learning; autonomous systems; human computer interfaces; enterprise software-as-a-service; cybersecurity; digital health and medical technology; novel materials; and quantum technologies.

The vehicle supports its portfolio companies through the commercialisation of new technologies, applications and materials, recruiting management teams, and helping startups to secure future investments.

Amadeus V Technology Fund has made 16 investments to date, including rounds in Xampla, which specialises in replacing micro-plastics with plant protein material; Riverlane, a quantum software company; XYZ Reality, which offers augmented reality technology; and Ori Biotech, a specialist in cell and gene therapy.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• UK / Ireland
• Technology
• Amadeus Capital Partners Ltd
• United Kingdom
• Venture